MRNA

Hebrew University study finds zebrafish provides clues to RNA's role in embryo formation

A new study at the Hebrew University in Jerusalem (HU) presents insights into mRNA regulation during embryonic development in zebrafish.

 A 3D model of mRNA is displayed on the day of opening of German pharmaceuticals company BioNtech mRNA vaccine manufacturing plant to serve the African market in Kigali, Rwanda December 18, 2023.
A coronavirus vaccine dose is seen being administered at a Meuhedet vaccination center in Jerusalem, on February 16, 2021.

World's first: Patients treated with new cancer vaccine

 Nobel prize

Jewish American scientist wins Nobel Prize in Medicine for COVID vaccines

 Vaccination

3D printed microneedle patches can help bring vaccines to the masses


What's behind the recent Moderna cancer ‘vaccine’ announcement?

World-renowned Hebrew University cancer researcher urges caution about claimed ‘breakthrough’ and terminology.

A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020

mRNA could make flu vaccines more effective - here's how

The World Health Organization reported that as many as 5 million people suffer from severe cases of influenza each year.

THE MRNA TECHNIQUE may mean that future pandemics can be dealt with far more quickly.

Moderna says new RSV vaccine 84% effective in older adults

Moderna intends to submit the RSV vaccine for regulatory approval in the first half of 2023.

A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020

Israel researchers discover 100,000 new RNA viruses

RNA viruses infect cells by injecting RNA into the cytoplasm of the host cells to transcribe and replicate viral proteins.

3D scan of SARS-CoV-2 virus particles created by design lab Nanographics

Sheba Medical Center and the US NIH to establish Pandemic Research Institute

The institute will work with the NIH and research innovative techniques to discover new pathogens and predict future threats.

 Sheba Medical Center and the NIH launch new research center.

Moderna to launch phase III trials for mRNA cancer vaccine

The mRNA technology used in Moderna's cancer vaccine is built off of what was used in their COVID-19 vaccine.

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020

Moderna sues Pfizer and BioNTech over COVID-19 vaccine

Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

COVID-19 mRNA vaccines safe to use during pregnancy, study finds

Four percent more unvaccinated pregnant women had health complications than pregnant women who received the mRNA vaccine against COVID-19 after a week in a new study.

 Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.

Pfizer or Sinovac: Which COVID-19 vaccine booster is best? - study

A study on nearly 14 million people in Malaysia who were vaccinated with Pfizer, Sinovac or a combination of the two seems to indicate that Pfizer offers stronger protection.

Coronavirus vaccine under development (illustrative)

Israeli researchers develop AI machine-learning tool for cancer therapy

Their discovery is significant because it eliminates the need to compare the RNA from the tumor to DNA from healthy cells.

 Cancer Immunotherapy by  NIH Image Gallery.

Prior COVID offers less protection vs Omicron; mRNA booster shot efficacy declines within months

The immune response to COVID-19 helps protect against reinfection, but that protection is weaker against Omicron than it was against earlier variants of the coronavirus, according to new data.

 A NURSE prepares a dose of the COVID-19 vaccine as the new Omicron variant spreads, in Dutywa, in Eastern Cape province, South Africa this week.